Google trend analysis Afrezza vs Toujeo vs Tresiba

[LosingMyBullishness]

Relative trend comparision using google trends:
Blue: Afrezza
Red: Toujeo
Yellow: Tresiba
Time intervall: 12 month
Region: U.S.
Categories: All

The volume is too small to verify a shift from NY and CA to a broader regional interest, but a comparision of 12m vs 7d gives some indication.

My take-aways:
- Huge marketing budgets work, social media for afrezza had no effect yet.
- Afrezza searches are mainly by investors or early adopters, Toujeo searches are by doctors and patients. Indication based on kind of search Toujeo leads significantly for web searches. Afrezza is basically alone when filtering by News searchesSadly embedding the script that links directly to google trend does not work here so

Link to comparision at google trends

Some other  inside I found remarkable:
- On a world-wide comparision there have been no significant searches from other countries beside U.S. --> There is basically no awareness beyond the U.S.

[benyiju]

Well, that sucks.

[LosingMyBullishness]

True. At least we have a (declining) baseline to evaluate the success of future marketing against. You can see (when you filter Feb 2015 to Feb 16) the increase of awareness of Toujeo marketing against Afrezza. For me another proof of SNY's lack of marketing effort: They did not create awareness in the first place: it was not just not subscribed due to spiro issues, price, insurance etc., but it was not googled.

[esstan2001]

I would think that in making his case for a partner or more $, Matt will need 10 presentation slides highlighting all the objective, clear evidence that Sanofi did not market Afrezza. The deck needs to include these google trends results, excerpts of the Amy T ADA report, the Dance CEO comments, and any other similar published article comments. A review of this board would make an excellent starting point. 

[esstan2001]

Feb 11, 2016 9:15:09 GMT -5 esstan2001 said:

I would think that in making his case for a partner or more $, Matt will need 10 presentation slides highlighting all the objective, clear evidence that Sanofi did not market Afrezza. The deck needs to include these google trends results, excerpts of the Amy T ADA report, the Dance CEO comments, and any other similar published article comments. A review of this board would make an excellent starting point. 

And I am sure there are professional research outfits that can provide ad metrics for Matt to cite also; just requires some $...

[mnholdem]

Here is another source (you can click on other country flags to inspect ex-U.S. Afrezza webtraffic ):

www.semrush.com/info/afrezza.com

[Deleted]

Feb 11, 2016 9:15:09 GMT -5 esstan2001 said:

I would think that in making his case for a partner or more $, Matt will need 10 presentation slides highlighting all the objective, clear evidence that Sanofi did not market Afrezza. The deck needs to include these google trends results, excerpts of the Amy T ADA report, the Dance CEO comments, and any other similar published article comments. A review of this board would make an excellent starting point. 

I feel like any big pharma will know what the deal was. Its not secreacy to these guys. If certain funds had access to knowing Afrezza was going to be back burnered I think big pharma has to know also.

[symbil]

www.google.de/trends/explore#q=Afrezza%2C%20Toujeo%2C%20Tresiba%2C%20Jublia&geo=US&date=today%2012-m&cmpt=q&tz=Etc%2FGMT-1

They've been on TV since shortly after approval